Isomorphic Labs
From Wikipedia the free encyclopedia
| Company type | Subsidiary |
|---|---|
| Industry | Drug discovery |
| Founded | 1 November 2021  |
| Founder | Demis Hassabis |
| Headquarters | London |
Key people | |
| Parent | Alphabet Inc. |
| Website | isomorphiclabs |
Isomorphic Labs Limited[1] is a London-based drug discovery company, which uses artificial intelligence for drug discovery.[2][3][4] Isomorphic Labs was founded by Demis Hassabis.[5][3] The company was incorporated on February 4, 2021 and announced on November 5, 2021.[2][6] It was established under Alphabet Inc. as a spin-off from its AI research lab DeepMind.[2][3][6] Hassabis is the CEO and founder.[3]
The company draws upon DeepMind's AlphaFold 2 technology, which can be used to predict protein structures in the human body with high accuracy, allowing its researchers to find new target pathways for drug delivery.[6][7]
In December 2022, Isomorphic Labs announced its second office location in Lausanne, Switzerland.[6][8]
In January 2024, Isomorphic Labs partnered with Novartis AG and Eli Lilly & Company to work together on AI drug discovery and research.[9]
References[edit]
- ^ "ISOMORPHIC LABS LIMITED overview - Find and update company information - GOV.UK". Companies House. February 24, 2021. Retrieved August 20, 2023.
- ^ a b c Shead, Sam (November 5, 2021). "Google-parent Alphabet has set up a new lab that will use A.I. to try to discover new drugs". CNBC. Archived from the original on November 5, 2021. Retrieved November 9, 2021.
- ^ a b c d Coldewey, Devin (November 4, 2021). "Isomorphic Labs is Alphabet's play in AI drug discovery". TechCrunch. Retrieved August 23, 2022.
- ^ Crist, Ry (November 4, 2021). "Alphabet launches Isomorphic Labs, an AI-driven drug discovery startup". CNET.
- ^ Shead, Sam (November 5, 2021). "Google-parent Alphabet has set up a new lab that will use A.I. to try to discover new drugs". CNBC. Retrieved November 30, 2023.
- ^ a b c d Criddle, Cristina; Johnston, Ian (December 3, 2022). "DeepMind spin-off steps up effort to use AI to create new drugs". Financial Times. Archived from the original on December 5, 2022. Retrieved April 28, 2023.
- ^ Quach, Katyanna (November 8, 2021). "Alphabet launches new AI drug discovery startup, Isomorphic Labs, led by DeepMind CEO". The Register. Archived from the original on November 27, 2022. Retrieved April 28, 2023.
- ^ Aaron Hurst (December 5, 2022). "DeepMind spin-off Isomorphic Labs announces drug discovery scale plans". Information Age.
- ^ Barton, Samantha (January 8, 2024). "Alphabet's Isomorphic Labs to collaborate with Novartis, Lilly on AI-driven drug discovery". Fortune.
External links[edit]
| Subsidiaries |
| ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| People |
| ||||||||||||||
 | This Google-related article is a stub. You can help Wikipedia by expanding it. |